Changes in epidermal CD11c+ cells in responders and non-responders in 70mg QD apilimod cohort.

Results shown are the number of epidermal CD11c+ cells in individual patients categorized as either responders (left, n  =  7) or non-responders (right, n  =  7) in the 70mg QD cohort at baseline (week 0), week 2, 6, and 12.